ZHAO Zhuo,LIU Lin,SONG Nan,et al.Effect of Banxia Xiexintang on NLRP3/Caspase-1 Pyroptosis Pathway in Rats with Ulcerative Colitis[J].Chinese Journal of Experimental Traditional Medical Formulae,2022,28(16):29-34.
ZHAO Zhuo,LIU Lin,SONG Nan,et al.Effect of Banxia Xiexintang on NLRP3/Caspase-1 Pyroptosis Pathway in Rats with Ulcerative Colitis[J].Chinese Journal of Experimental Traditional Medical Formulae,2022,28(16):29-34. DOI: 10.13422/j.cnki.syfjx.202201003.
Effect of Banxia Xiexintang on NLRP3/Caspase-1 Pyroptosis Pathway in Rats with Ulcerative Colitis
To explore the effect of Banxia Xiexintang (BXT) on the NOD-like receptor protein 3 (NLRP3)/cysteinyl aspartate-specific protease-1 (Caspase-1) pyroptosis pathway and its downstream factors in rats with ulcerative colitis (UC), and to explain the mechanism of BXT in the treatment of UC.
Method
2
SD rats were randomly divided into normal control group, model group, low- and high-dose BXT groups (6.3, 12.6 g·kg
-1
·d
-1
), and salazosulfapyridine (SASP) group (0.42 g·kg
-1
·d
-1
), with 7 rats in each group. The UC model was induced by intragastric administration of 2.5% dextran sodium sulfate (DSS) solution for 10 days, followed by drug intervention for 7 days. The general state of rats was observed during the experiment, and the disease activity index (DAI) score was calculated during the administration period. At the end of the experiment, colonic tissues were collected for hematoxylin-eosin (HE) staining to observe the pathological changes and the curative effect of BXT. Real-time fluorescence-based quantitative polymerase chain reaction (Real-time PCR) was used to detect the mRNA transcriptional levels of NLRP3, Caspase-1, gasdermin D (GSDMD), and interleukin (IL)-1
β
in colonic tissues. Western blot was used to detect the protein expression of NLRP3, Caspase-1, GSDMD, and IL-1
β
in colonic tissues to explore the therapeutic mechanism of BXT.
Result
2
Compared with the normal control group, the model group showed increased DAI score, pathological changes in colonic tissues, and up-regulated mRNA and protein expression of NLRP3, Caspase-1, GSDMD, and IL-1
β
(
P
<
0.05,
P
<
0.01). Compared with the model group, the groups with drug intervention showed reduced DAI scores and improved pathological changes in colonic tissues. The mRNA and protein expression levels of NLRP3, Caspase-1, GSDMD, and IL-1
β
in colonic tissues of the BXT groups were significantly down-regulated or tended to be down-regulated, especially in the low-dose BXT group (
P
<
0.05,
P
<
0.01).
Conclusion
2
BXT can inhibit pyroptosis and alleviate inflammation in rats with UC by regulating the NLRP3/Caspase-1 pathway.
关键词
Keywords
references
SUNG H , FERLAY J , SIEGEL R L , et al . Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J]. CA Cancer J Clin , 2021 , 71 ( 3 ): 209 - 249 .
OLéN O , ERICHSEN R , SACHS M C , et al . Colorectal cancer in ulcerative colitis: A Scandinavian population-based cohort study [J]. Lancet , 2020 , 395 ( 10218 ): 123 - 131 .
LU F , LAN Z , XIN Z , et al . Emerging insights into molecular mechanisms underlying pyroptosis and functions of inflammasomes in diseases [J]. J Cell Physiol , 2020 , 235 ( 4 ): 3207 - 3221 .
KANTONO M , GUO B . Inflammasomes and cancer: The dynamic role of the inflammasome in tumor development [J]. Front Immunol , 2017 , 8 : 1132 .
RANSON N , VELDHUIS M , MITCHELL B , et al . NLRP3-dependent and -independent processing of interleukin (IL)-1 β in active ulcerative colitis [J]. Int J Mol Sci , 2018 , 20 ( 1 ): 57 .
RANDHAWA P K , SINGH K , SINGH N , et al . A review on chemical-induced inflammatory bowel disease models in rodents [J]. Korean J Physiol Pharmacol , 2014 , 18 ( 4 ): 279 - 288 .
KELLER D S , WINDSOR A , COHEN R , et al . Colorectal cancer in inflammatory bowel disease: Review of the evidence [J]. Tech Coloproctol , 2019 , 23 ( 1 ): 3 - 13 .
BYE W A , NGUYEN T M , PARKER C E , et al . Strategies for detecting colon cancer in patients with inflammatory bowel disease [J]. Cochrane Database Syst Rev , 2017 , 9 ( 9 ): CD000279 .
NAKASE H , UCHINO M , SHINZAKI S , et al . Evidence-based clinical practice guidelines for inflammatory bowel disease 2020 [J]. J Gastroenterol , 2021 , 56 ( 6 ): 489 - 526 .
STROWIG T , HENAO-MEJIA J , ELINAV E , et al . Inflammasomes in health and disease [J]. Nature , 2012 , 481 ( 7381 ): 278 - 286 .
LAZARIDIS L D , PISTIKI A , GIAMARELLOS-BOURBOULIS E J , et al . Activation of NLRP3 inflammasome in inflammatory bowel disease: Differences between Crohn's disease and ulcerative colitis [J]. Dig Dis Sci , 2017 , 62 ( 9 ): 2348 - 2356 .
SHAO B Z , WANG S L , PAN P , et al . Targeting NLRP3 inflammasome in inflammatory bowel disease: Putting out the fire of inflammation [J]. Inflammation , 2019 , 42 ( 4 ): 1147 - 1159 .
LIN T J , YIN S Y , HSIAO P W , et al . Transcriptomic analysis reveals a controlling mechanism for NLRP3 and IL-17A in dextran sulfate sodium (DSS)-induced colitis [J]. Sci Rep , 2018 , 8 ( 1 ): 14927 .